| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BF02244617 |
| P698 | PubMed publication ID | 2138338 |
| P2093 | author name string | M A Geyer | |
| G S Tapson | |||
| L L Wing | |||
| P2860 | cites work | Psychotomimetic phenylisopropylamines. 5. 4-Alkyl-2,5-dimethoxyphenylisopropylamines | Q28214684 |
| Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist | Q28282022 | ||
| Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens | Q34167036 | ||
| LSD-induced alterations of investigatory responding in rats | Q39284473 | ||
| A characteristic effect of hallucinogens on investigatory responding in rats | Q39696364 | ||
| Inhibitory effect of chlorpromazine on the syndrome of hyperactivity produced by L-tryptophan or 5-methoxy-N,N-dimethyltryptamine in rats treated with a monoamine oxidase inhibitor | Q39985530 | ||
| Evidence that serotonin mediates some behavioral effects of amphetamine | Q40685983 | ||
| Effects of 5HT-1A agonists on locomotor and investigatory behaviors in rats differ from those of hallucinogens | Q41261687 | ||
| Subtypes of the 5-HT receptor mediating the behavioural responses to 5-methoxy-N,N-dimethyltryptamine in the rat. | Q41352922 | ||
| Habituation of tactile startle is altered by drugs acting on serotonin-2 receptors | Q41392825 | ||
| A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors | Q41740406 | ||
| Stimulant and hallucinogenic behavioral profiles of 3,4-methylenedioxymethamphetamine and N-ethyl-3,4-methylenedioxyamphetamine in rats. | Q42202646 | ||
| Effects in the X-maze anxiety model of agents acting at 5-HT1 and 5-HT2 receptors | Q42208682 | ||
| 5-HT depletion with 5,7-DHT, PCA and PCPA in mice: differential effects on the sensitivity to 5-MeODMT, 8-OH-DPAT and 5-HTP as measured by two nociceptive tests | Q44004357 | ||
| The effects of lysergic acid diethylamide and mescaline-derived hallucinogens on sensory-integrative function: tactile startle | Q44145571 | ||
| Differential effects of 5-hydroxytryptamine1a selective drugs on the 5-HT behavioral syndrome | Q45027380 | ||
| Receptor binding profile of R 41 468, A novel antagonist at 5-HT2 receptors | Q46927707 | ||
| [3H]quipazine labels 5-HT3 recognition sites in rat cortical membranes | Q48098328 | ||
| Identification of nonserotonergic [3H]ketanserin binding sites associated with nerve terminals in rat brain and with platelets; relation with release of biogenic amine metabolites induced by ketanserin- and tetrabenazine-like drugs. | Q48135129 | ||
| Neuropharmacological reassessment of the discriminative stimulus properties of d-lysergic acid diethylamide (LSD). | Q48251635 | ||
| Depletion of brain serotonin by 5,7-dihydroxytryptamine alters the response to amphetamine and the habituation of locomotor activity in rats | Q48559759 | ||
| Spike and wave complexes produced by four hallucinogenic compounds in the cat. | Q48592035 | ||
| Naloxone alters the effects of LSD, DOM and quipazine on operant behavior of rats. | Q48624266 | ||
| Effects of 5-methoxy-N,N-dimethyltryptamine on central monoamine neurons | Q48748951 | ||
| Dopaminergic activity of quipazine | Q49080323 | ||
| LSD-induced alterations of locomotor patterns and exploration in rats | Q49108240 | ||
| Species variations in 5-HT3 recognition sites labeled by 3H-quipazine in the central nervous system. | Q51764694 | ||
| A proposed animal model for hallucinogens based on LSD's effects on patterns of exploration in rats. | Q52495495 | ||
| Vascular effects of ketanserin (R 41 468), a novel antagonist of 5-HT2 serotonergic receptors | Q53946726 | ||
| Selective 5-HT1B agonists identify the 5-HT autoreceptor in lumbar spinal cord of rat | Q68298297 | ||
| Effects of DOM and DMT in a proposed animal model of hallucinogenic activity | Q69838660 | ||
| Multivariate assessment of locomotor behavior: pharmacological and behavioral analyses | Q69886468 | ||
| 8-Hydroxy-2-(di-n-propylamino)tetralin, a new centrally acting 5-hydroxytryptamine receptor agonist | Q70564470 | ||
| Antagonism of the effects of the hallucinogen DOM and the purported 5-HT agonist quipazine by 5-HT2 antagonists | Q71036856 | ||
| Evidence that 5-HT agonist-induced rotational behaviour in the rat is mediated via 5-HT1 receptors | Q72820782 | ||
| Patterns of exploration in rats distinguish lisuride from lysergic acid diethylamide | Q93622807 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 417-425 | |
| P577 | publication date | 1990-01-01 | |
| P1433 | published in | Psychopharmacology | Q1422802 |
| P1476 | title | 5HT-2 mediation of acute behavioral effects of hallucinogens in rats | |
| P478 | volume | 100 |
| Q48157750 | 5-HT receptor knockout mice: pharmacological tools or models of psychiatric disorders |
| Q30484420 | 5-HT(2A) and 5-HT(2C) receptors exert opposing effects on locomotor activity in mice |
| Q34119181 | A novel behavioral model that discriminates between 5-HT2A and 5-HT2C receptor activation |
| Q48591373 | Activation of 5-HT1C-receptors suppresses excessive wheel running induced by semi-starvation in the rat |
| Q52170511 | Activation of 5-HT2A receptors impairs response control of rats in a five-choice serial reaction time task. |
| Q30358201 | Behavioral and pharmacokinetic interactions between monoamine oxidase inhibitors and the hallucinogen 5-methoxy-N,N-dimethyltryptamine. |
| Q37230473 | Behavioral effects of α,α,β,β-tetradeutero-5-MeO-DMT in rats: comparison with 5-MeO-DMT administered in combination with a monoamine oxidase inhibitor |
| Q41694692 | Causes and consequences of the loss of serotonergic presynapses elicited by the consumption of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") and its congeners |
| Q43913204 | Cross-tolerance studies of serotonin receptors involved in behavioral effects of LSD in rats |
| Q35965775 | Differences in the locomotor-activating effects of indirect serotonin agonists in habituated and non-habituated rats |
| Q24594834 | Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice |
| Q38560369 | Differential ontogenesis of three DOI-induced behaviors in mice |
| Q46119966 | Dissociation of multiple effects of acute LSD on exploratory behavior in rats by ritanserin and propranolol |
| Q22252791 | Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis |
| Q45279141 | Effect of Hallucinogens on Unconditioned Behavior |
| Q48733578 | Effects of ketanserin on the discrimination of electrical stimulation of the dorsal raphé nucleus in rats |
| Q41972251 | Evidence that 5-HT2 receptor activation decreases noradrenaline release in rat hippocampus in vivo |
| Q99566402 | Hallucinations Under Psychedelics and in the Schizophrenia Spectrum: An Interdisciplinary and Multiscale Comparison |
| Q93118570 | Hallucinogen-Like Action of the Novel Designer Drug 25I-NBOMe and Its Effect on Cortical Neurotransmitters in Rats |
| Q22251224 | Hallucinogens |
| Q95644722 | Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin |
| Q46961611 | Mescaline effects on rat behavior and its time profile in serum and brain tissue after a single subcutaneous dose. |
| Q22251267 | Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists |
| Q35375608 | Modeling anxiety using adult zebrafish: a conceptual review |
| Q34087847 | Modification of the effects of 5-methoxy-N,N-dimethyltryptamine on exploratory behavior in rats by monoamine oxidase inhibitors |
| Q74506058 | Modulation of phencyclidine-induced changes in locomotor activity and patterns in rats by serotonin |
| Q24620764 | Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens |
| Q30435174 | Mutual independence of 5-HT(2) and α1 noradrenergic receptors in mediating deficits in sensorimotor gating |
| Q41428568 | Perspectives on the role of serotonergic mechanisms in the pharmacology of schizophrenia. |
| Q51526308 | Preweaning cocaine administration alters the adult response to quipazine: comparison with fluoxetine. |
| Q27027381 | Recent advances in the neuropsychopharmacology of serotonergic hallucinogens |
| Q37602790 | Role of the 5-HT₂A receptor in the locomotor hyperactivity produced by phenylalkylamine hallucinogens in mice |
| Q40619473 | Starvation-induced hyperactivity in the rat: the role of endocrine and neurotransmitter changes |
| Q43913055 | Subthalamic 5-HT(1A) and 5-HT(1B) receptor modulation of RU 24969-induced behavioral profile in rats |
| Q42633100 | The 5-HT(2) receptor activation enhances impulsive responding without increasing motor activity in rats |
| Q22251018 | The neurobiology of psychedelic drugs: implications for the treatment of mood disorders |
| Q37345260 | The receptor mechanisms underlying the disruptive effects of haloperidol and clozapine on rat maternal behavior: a double dissociation between dopamine D(2) and 5-HT(2A/2C) receptors |
| Q50257597 | Tolerance and Tachyphylaxis to Head Twitches Induced by the 5-HT2A Agonist 25CN-NBOH in Mice. |
| Q73327838 | alpha-Melanocyte-stimulating hormone (alpha-MSH) and melanin-concentrating hormone (MCH) modify monoaminergic levels in the preoptic area of the rat |
Search more.